Interpace Biosciences Announces Appointment of Vijay Aggarwal, Ph.D. as New Director
27. Januar 2022 16:05 ET
|
Interpace Biosciences, Inc.
PARSIPPANY, NJ, Jan. 27, 2022 (GLOBE NEWSWIRE) -- Interpace Biosciences , Inc. (OTCQX: IDXG) (“Interpace”) a leader in enabling personalized medicine, is pleased to announce today that Vijay...